--Broadridge Financial Solutions Keeps Quarterly Dividend at $0.80 a Share, Payable July 5 to Shareholders of Record June 14-March 2024-www.financetom.com

--Broadridge Financial Solutions Keeps Quarterly Dividend at $0.80 a Share, Payable July 5 to Shareholders of Record June 14

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Broadridge Financial Solutions Keeps Quarterly Dividend at $0.80 a Share, Payable July 5 to Shareholders of Record June 14

May 16, 2024 8:19 AM

11:04 AM EDT, 05/16/2024 (MT Newswires) --

Price: 202.81, Change: +0.69, Percent Change: +0.34

Previous page： Arcutis Biotherapeutics Receives Approval in Canada for Skin Disease Cream Zoryve Next page： --Street Color: Lamb Weston Pushed by Activist Investor Jana Partners to Consider Sale, Wall Street Journal Reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Arcutis Biotherapeutics Receives Approval in Canada for Skin Disease Cream Zoryve

Oct 18, 2024

08:48 AM EDT, 10/18/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Friday that its Arcutis Canada subsidiary has received regulatory approval from Health Canada for Zoryve topical foam 0.3% to treat seborrheic dermatitis in patients aged 9 and older. The approval was based on data from a phase 3 study, along with findings from a phase 2 study,...

--Street Color: Lamb Weston Pushed by Activist Investor Jana Partners to Consider Sale, Wall Street Journal Reports

Oct 18, 2024

08:47 AM EDT, 10/18/2024 (MT Newswires) -- Price: 76.32, Change: +5.32, Percent Change: +7.49 ...

Activist investor Jana Partners builds about 5% stake in Lamb Weston, WSJ reports

Oct 18, 2024

Oct 18 (Reuters) - Activist investor Jana Partners has built a stake of about 5% in frozen fries supplier Lamb Weston ( LW ) , the Wall Street Journal reported on Friday, citing people familiar with the matter. ...

Gilead voluntarily withdraws urothelial cancer drug in US

Oct 18, 2024

Oct 18 (Reuters) - Gilead Sciences ( GILD ) said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients with a type of urothelial cancer after consultation with the regulator. (Reporting by Sneha S K) ...